Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year. 2025 was a slow year for IPOs, with ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Generate is indicative of a more mature startup that may have a better chance of succeeding in today’s markets. Industry IPOs peaked in 2021, resulting in a flood of companies whose early science didn ...
A Naples waterfront spec mansion developed by a team that included Portillo’s founder Dick Portillo sold for over $15.1 million, marking the first deal to close from a trio of high-end Florida ...
Humble is about to get a taste of Chicago comfort food. Portillo’s is set to debut its long-awaited Humble location on Feb. 24, complete with a morning ribbon cutting that brings the chain’s ...
Eva Longoria has shared a sobering message with her followers amid ongoing political turmoil and public grief following the fatal shooting of Alex Pretti. Minneapolis erupted into demonstrations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results